Chair, ResMed

Peter Farrell

Role	Organisation	Sources
Chair	ResMed	Forbes Australia

Coverage

Stories naming Peter Farrell. Where several outlets covered the same round, they are bundled under whichever ran the fullest account.

News

Find out how this Australian med-tech company is tackling Parkinson's disease

Profile of SYMBYX, an Australian medtech firm using light therapy lasers to ease Parkinson's symptoms, naming its high-profile investors including ResMed's Peter Farrell and noting clinical trials underway.

Forbes Australia Mon 24 Oct 2022 GrainCorp Harvard Life Sciences Project ResMed SYMBYX Graham Bradley Professor Jonathan West Peter Farrell Wayne Markman

Something wrong? Tell us

Peter Farrell

Roles

Coverage

Find out how this Australian med-tech company is tackling Parkinson's disease